Physician profile
Simon Okewole
NPI 1205000296
$30,213.28
in general payments reported to CMS, 2019-2025
31 companies · $3,721 in 2025
The $3,721 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,364 · 2020: $958 · 2021: $11K · 2022: $7,135 · 2023: $2,017 · 2024: $2,326 · 2025: $3,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,432 · Travel and Lodging: $2,154 · Honoraria: $1,114 · Consulting Fee: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,432.18 |
| Travel and Lodging | $2,153.82 |
| Honoraria | $1,114.00 |
| Consulting Fee | $363.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $18,587.17 | 2019-2025 | Ecm Patch,Pouch |
| Atricure, INC. | $2,732.24 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Biosense Webster, INC. | $2,434.34 | 2019-2025 | Carto 3, Qdot Micro Catheter, Qdot Micro |
| Boston Scientific Corporation | $2,276.38 | 2019-2025 | Watchman Flx, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Medical Device Business Services, INC. | $1,917.12 | 2019 | |
| Medtronic, INC. | $235.38 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $211.70 | 2019-2021 | |
| Medtronic Vascular, INC. | $194.58 | 2019-2020 | |
| Biotronik INC. | $177.03 | 2022 | |
| Janssen Pharmaceuticals, INC | $169.62 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $152.03 | 2023-2025 | Eliquis, Camzyos |
| Pfizer INC. | $150.48 | 2021-2025 | |
| Abbott Laboratories | $143.85 | 2019 | |
| Cvrx, INC. | $109.95 | 2023 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $102.76 | 2020-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $90.60 | 2024 | |
| Nuwellis, INC. | $74.95 | 2024 | Aquadex Smartflow Console |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.75 | 2019-2023 | Lifevest |
| Amgen INC. | $53.65 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.34 | 2019-2022 | |
| Baxter Healthcare | $42.85 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Ge Healthcare | $39.80 | 2020 | |
| Intact Vascular, INC. | $34.47 | 2019 | |
| Lilly USA, LLC | $32.93 | 2023 | Jardiance |
| Altathera Pharmaceuticals LLC | $32.85 | 2023 | Sotalol Hydrochloride |
| Inspire Medical Systems, INC. | $27.25 | 2025 | Inspire |
| Siemens Medical Solutions USA, INC. | $25.08 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.17 | 2019 | |
| Bardy Diagnostics, INC. | $17.00 | 2019-2020 | |
| Cardiva Medical, INC. | $15.15 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Actelion Pharmaceuticals US, INC. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Okewole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.